31 results about "Attention deficit" patented technology

Disclosed are compounds, and corresponding methods of treatment, that activate myocyte-specific enhancer factor 2 (MEF2) transcriptional activity that are therefore useful in treating deficits in MEF2C activity found in autism spectrum disorder (ASD), intellectual disability (ID), attention deficit and hyperactivity disorder (ADHD), and in diseases characterized by cognitive decline such as Alzheimer's disease (AD), Lewy body dementia (LED), Frontotemporal dementia (FTD), and other forms of dementia, as well as movement disorders such as Parkinson's disease (PD) and parkinsonism from other causes.

The present invention relates a method of treating attention-deficit / hyperactivity disorder (ADHD), wherein the patient suffers from mood disorders and / or anxiety. More specifically, the present invention is directed to a method of using a carbamate compound alone or in combination with other medications, for the treatment of ADHD.

1. The name of the design product: eye movement cognitive and attention assessment training instrument. 2. The use of the design product: for attention deficit groups such as hyperactivity and autism. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: perspective view 1.

The invention provides psychology attention training equipment, and belongs to the technical field of psychology teaching. Comprising a supporting assembly, a box body assembly is arranged at the upper end of the supporting assembly, a notch is formed in the middle of the front end of the box body assembly, the transverse diameter and the longitudinal diameter of the notch are matched with the transverse diameter and the longitudinal diameter of a displacement assembly, and a mounting assembly is arranged at the upper end of the box body assembly. The I-shaped base, the frame, the square frame and the top box are arranged and spliced into a small compartment with only one entrance and exit, meanwhile, the small compartment is closed in cooperation with the L-shaped frame, follow-up training is conducted in the small compartment, a relatively-closed personal space is provided for students and children who leave the familiar environment and have social terrorism and self-closing, and therefore the students and children can carry out training conveniently and rapidly. According to the invention, interference of an external environment is reduced, a self-adjusting space is reserved, and an obvious social avoidance demand is met, so that the people can relax the mind more easily and reduce anxiety and nervous mood, and thus the people can concentrate on attention deficit training.

This application relates to a method, apparatus, and device for screening the risk of reading and attention deficit disorder in children. The method includes acquiring multi-channel raw brain blood oxygenation signals under task-induced conditions using a specific layout fNIRS array integrated into a wearable headband, based on a rapid naming cognitive paradigm. Based on the raw brain blood oxygenation signals, a fusion feature vector representing the reading and attention networks is generated by calculating temporal waveform features and frontotemporal functional connectivity strength. The multi-dimensional fusion feature vector is then processed and analyzed using a Transformer classification model to generate classification results indicating the risk level of reading disorders and comorbid ADHD. This application achieves portable and rapid brain function signal acquisition by integrating a targeted fNIRS array with a standardized cognitive paradigm. By fusing temporal dynamics and brain network connectivity features, a multi-dimensional neural representation is constructed. Finally, a lightweight Transformer model is used to output the risk level of reading disorders and comorbid ADHD end-to-end, achieving high-precision automated assisted screening.

The invention relates to a pellet as well as a preparation method and application thereof. The pellet has a treatment effect on attention deficit and attention disorder of children. The invention also provides a tablet containing the pellet, the tablet comprises active pharmaceutical ingredients and pharmaceutically acceptable auxiliary materials, and the active pharmaceutical ingredients exist in the core pellet. The pellet and the tablet containing the pellet have a good release characteristic.

The invention discloses an attention enhancement brain-computer interface system based on binocular color competition, and belongs to the technical field of biomedical information. According to the system, electroencephalogram (EEG) data when a user watches a binocular color competition normal form is collected through an electroencephalogram cap, the collected EEG data is classified and recognized by using deep learning, man-machine interaction design is performed by using a neural feedback technology on the basis, adjustment of a neural network of the user is promoted through sound and image modes, and attention enhancement is realized. A new training mode can be provided for the attention deficit patient, and technical support is provided for application of the brain-computer interface technology in the education field.

The present invention provides cilnidipine, nilvadipine, isradipine, felodipine, verapamil, nimodipine or nifedipine, or a pharmaceutically acceptable salt or solvate thereof, for use in the treatment or prophylaxis of Attention Deficit / Hyperactivity Disorder (ADHD). The invention also provides kits and methods for the treatment or prophylaxis of ADHD.

The invention discloses a children attention deficit early intelligent screening system based on multi-modal behavior feature fusion. The system comprises a data acquisition module, a data processing module and a data classification judgment module. The data acquisition module is used for acquiring handwriting data, action feature data and facial expression feature data of a child; the data processing module is used for performing space-time alignment and feature level fusion on the acquired handwriting data, action feature data and facial expression feature data to obtain processed data; and the data classification and judgment module is used for carrying out classification and judgment on the processed data to obtain a screening result and finish early intelligent screening of the attention deficits of children. According to the invention, the Microsoft Surface touch device and the external camera are used for collecting the bottom data in the drawing process of children in real time, and computer vision and a machine learning algorithm are combined, so that the attention defect screening function is realized.

The invention discloses application of a Duchenne muscular dystrophy drug in attention deficit and hyperactivity disorder and a product, and belongs to the technical field of bioengineering. Through a zebra fish attention deficit and hyperactivity disorder model, the inventor team finds that the Duchenne muscular dystrophy medicine has the effects of improving attention deficit and hyperactivity disorder diseases and has statistical significance. Therefore, when the Duchenne muscular dystrophy medicine is applied to preparation of products for treating attention deficit and hyperactivity disorder, a reliable theoretical basis is provided for a new treatment scheme.

The invention belongs to the technical field of traditional Chinese medicines, and particularly discloses a traditional Chinese medicine composition for treating tourette syndrome combined attention deficit in children, a preparation, a preparation method and application. The traditional Chinese medicine composition is composed of radix bupleuri, fossil fragments, oysters, radix scutellariae, fresh ginger, ginseng, cassia twigs, poria cocos, pinellia ternate, Chinese dates, rhizoma acori graminei, uncaria rhynchophylla, fructus forsythiae, licorice roots and other medicinal materials, and has the effects of calming liver wind, reducing phlegm, inducing resuscitation, invigorating spleen, replenishing qi and harmonizing ying and wei. The traditional Chinese medicine composition is definite in curative effect, small in side effect and high in safety, and the effect is better than that of chemical medicines. The traditional Chinese medicine composition has a remarkable clinical curative effect on children tic disorder combined with attention deficit, especially liver wind internal movement phlegm entraining syndromes, and has a wide market popularization and application prospect.

The present invention relates to a suction fidget tube, specifically designed to provide entertainment and engagement for children during travel, as well as in various settings such as church, school, or home. Each package contains 4 individually wrapped Telescopic Suction Cup Robot Toy travel toy characters in vibrant opaque colors, meticulously crafted to provide a strong and safe experience. The Telescopic Suction Cup Robot Toy is ideal for igniting imaginations, promoting creativity, and offering relief for those with attention deficits, making it a versatile and essential accessory for children of all ages.

The system comprises a prediction module (1) equipped with artificial intelligence to predict neurological disorders in an individual patient and identify a level of neurological disorders; a central processing unit (2) to detect triggering events and circumstances due to which the neurological disorders trigger in an individual patient upon receiving real-time behavior information data generated by a playing ball (3) of an individual patient and distinguish between a normal behavior and a neurological disorders behavior; an alert module (4) to alert the individual patient upon determining neurological disorders behavior; and an entertainment platform (5) to entertain and engage the individual patient with a specific set of activities assigned according to detected triggering events and circumstances upon determining the neurological disorders behavior, wherein a specific set of activities includes listening to music, playing games, and talking to an AI chatbot.

The invention relates to a multifunctional medicine release composition as well as a preparation method and application thereof. The multifunctional medicine release composition has a treatment effect on attention deficit and attention disorder of children. The invention also provides a dispersible sustained-release multi-unit pellet system which comprises an active pharmaceutical ingredient and pharmaceutically acceptable auxiliary materials, and the active pharmaceutical ingredient exists in the core pellet. The invention also relates to a method for preparing the sustained-release multi-unit pellet system by adopting a multi-seal coating technology. The dispersible slow-release multi-unit pellet system disclosed by the invention has a good release characteristic.

The invention relates to the technical field of screening and application of probiotics, in particular to bifidobacterium lactis HC2786 for reducing and removing harm of heavy metal in a body and application of the bifidobacterium lactis HC2786. The bifidobacterium anaticum subsp. Lactis HC2786 is preserved in the China Center for Type Culture Collection (CCTCC), the preservation number is CCTCC NO: M 20222008, and the preservation date is December 23, 2022, the preservation number is CCTCC NO: M 20222008, the preservation number is CCTCC NO: M 20222008, and the preservation number is CCTCC NO: M 20222008. The strain has a relatively strong adsorption effect on heavy metals such as mercury, silver, cadmium and chromium, is not easy to desorb, can reduce the accumulation level of various heavy metals in a central nervous system, alleviates the toxic action of the heavy metals on the nervous system, effectively improves hyperactivity, anxiety and dysphoria, spatial memory disorder, attention deficit and other hyperactivity disorder related neurological behavior abnormalities, and has a good application prospect. The method has great application value.

The invention involves novel, oral solutions of bitter drugs using Vitamin E TPGS as a masking agent and methods of using the same (e.g., for treating attention deficit / hyperactivity disorder (ADHD)). Atomoxetine (e.g., Atomoxetine HCl) is an example of a bitter drug whose bitterness can be masked by the presence of Vitamin E TPGS alone or in combination with additional ingredients.

The invention involves novel, oral solutions of bitter drugs using Vitamin E TPGS as a masking agent and methods of using the same (e.g., for treating attention deficit / hyperactivity disorder (ADHD)). Atomoxetine (e.g., Atomoxetine HCl) is an example of a bitter drug whose bitterness can be masked by the presence of Vitamin E TPGS alone or in combination with additional ingredients.

The present invention discloses a system and apparatus for constructing an attention deficit disorder animal model. The present invention discovers for the first time that the Calhm2V136G point mutation is a key molecule affecting attention, and that a mouse model carrying the Calhm2V136G point mutation exhibits attention deficit disorder. Based on this, the present invention creatively develops a system and apparatus for constructing an attention deficit disorder animal model carrying the Calhm2V136G point mutation. The present invention provides an effective animal model for studying the mechanism of action of attention deficit disorder or related diseases and for drug screening, and has broad application prospects.

The application provides a detection method for attention deficit hyperactivity disorder based on BOLD signals, the correlation features of the BOLD signals are extracted through a functional connection extraction network, then the time features of the BOLD signals are extracted through a time feature extraction network, the correlation features and the time features of the BOLD signals are fused, finally, a detection network is established based on a Softmax function, and the sample obtained through the feature fusion is input into the detection network to obtain a detection result; the application not only considers the fluctuation features of the BOLD signals in the time dimension, but also calculates the functional connections through the BOLD signals to further enhance the features and improve the classification accuracy, the multiple functional connections can be expressed at the same time through one output, the nonlinear features between the BOLD signals can be extracted, and the problems of too many features based on the traditional Pearson functional connection features and the linear correlation that can only be calculated are solved to a certain extent.

The present invention relates a method of treating attention-deficit / hyperactivity disorder (ADHD), wherein the patient suffers from mood disorders and / or anxiety. More specifically, the present invention is directed to a method of using a carbamate compound alone or in combination with other medications, for the treatment of ADHD.

An orally disintegrating pharmaceutical tablet comprising: between 0.1 and 21 wt % of cariprazine or its pharmaceutically acceptable salts, between 0.1 and 15 wt % of a disintegrant, between 0.1 and 5 wt % of colloidal silicon dioxide, between 0.1 and 10 wt % of a taste masking agent, between 0.1 and 5 wt % of a lubricant, and up to 100 wt % of a diluent, the percentage being expressed with regard to the total weight of the pharmaceutical tablet. Said composition for use in the treatment and / or prevention of pathological conditions which require the modulation of dopamine receptors, selected from the group of psychoses, drug abuse, cognitive impairment accompanying schizophrenia, mild-to-moderate cognitive deficits, dementia, psychotic states associated with dementia, eating disorders, attention deficit disorders, hyperactivity disorders in children, psychotic depression, bipolar disorder, paranoid and delusional disorders, dyskinetic disorders, anxiety, sexual dysfunction, sleep disorders, emesis, aggression and autism.

The present disclosure is concerned with benzothiazone compounds that are capable of inhibiting Tau-SH3 signaling. The present disclosure is also concerned with methods of using these compounds for the treatment of neurological disorders such as, for example, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, epilepsy, autism spectrum disorders, Parkinson's disease, spinal muscular atrophy, traumatic brain injury, vascular dementia, Huntington's disease, mental retardation, and attention deficit and hyperactivity disorder (ADHD). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

The invention discloses a child attention deficit test method integrating a gamification task, and relates to the technical field of child physical examination, and the method comprises the steps: presenting a series of interactive digital games with cognitive load to a tested individual by using a self-adaptive task generation engine; behavior response signals, physiological electric signals and kinematics signals generated in the process that the individuals participate in the interactive digital game are synchronously collected; calculating a dynamic cognitive state vector of the individual in real time according to the collected signals; and performing conjoint analysis on difficulty parameters adopted by the whole series of interactive digital games and dynamic cognitive state vectors fed back by the difficulty parameters to generate a final test report. According to the method, the defects of high subjectivity, single data and the like of a traditional evaluation method are effectively overcome through fusion of the self-adaptive game task and the multi-modal data; by capturing the dynamic change of the cognitive state of the child in real time, personalized accurate evaluation is realized.

The present disclosure is concerned with small molecule modulators of KLF15 signaling useful for treating various disorders such as, for example, kidney disease (e.g., chronic kidney disease), heart disease, obesity, or a neurodegenerative disorder (e.g., amyotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, spinal muscular atrophy, traumatic brain injury, vascular dementia, Huntington's disease, mental retardation, and attention deficit and hyperactivity disorder (ADHD)). This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.

Method for improving or eliminating a driver's attention deficit when driving an ego vehicle with a technical system for automatic or semi-automatic driving, in which the technical system determines that a first section of the route in which automatic or semi-automatic driving is possible at level X transitions into a second section in which automatic or semi-automatic driving at level X is no longer safely possible, so that the driver has to return to the starting point within a specified recovery time (t R ) must actively take more control over the vehicle again, the end of the first section of the route is indicated to the driver by a first signal, e.g. optical, after a predetermined or predeterminable time after the start of the output of the first signal via an interface in which the technical system is connected to an automatic climate control system (50) of the ego vehicle, the automatic climate control system (50) is activated and / or preset, and the driver, if he returns after expiry or partial expiry of the specified return time (t R ) does not react or does not react appropriately, is actively blown by the automatic climate control (50), wherein the automatic climate control system (50) comprises at least one electronically controlled air vent (51, 52, 53) and at least one parameter of the air flow flowing out of the air vent (51, 52, 53) onto the driver of the ego vehicle is set by the control unit (90), and wherein the air flow is directed by the automatic climate control system (50) directly onto the face or the eye area of the driver, wherein a direction and / or intensity of the air flow onto the eye area of a spectacle wearer can differ from the direction of the air flow of a non-spectacle wearer.

The invention discloses an ADHD and subtype diagnosis method based on a deep network. The ADHD and subtype diagnosis method based on the deep network comprises the following steps: establishing a sight tracking network CognittionNet; the method comprises the following steps: acquiring an attention signal At (t) and an iris signal Ir (t) by using a front short video input CognittionNet of a person to be detected; the variance (Atstd) and the average change speed (Atvmean) of At (t) are counted; counting the average change speed (Irvmean) of the Ir (t); judging whether the person to be detected is ADHD or non-ADHD; and judging and confirming whether the ADHD patient belongs to an attention deficit type (ADHD-I), a hyperactivity impulse type (ADHD-II) or a hybrid type (ADHD-III). Therefore, the objective diagnosis of the ADHD and the subtype thereof can be realized by only adopting one short video.

The present invention provides aceclofenac, amlodipine or doxazosin, or a pharmaceutically acceptable salt or solvate thereof, for use in the treatment or prophylaxis of Attention Deficit / Hyperactivity Disorder (ADHD). The invention also provides kits and methods for the treatment or prophylaxis of ADHD.

Disclosed herein are methods of treating attention deficit / hyperactivity disorder (ADHD), major depressive disorder (MDD), binge eating disorder (BED), or shift work disorder (SWD) in a human, such as an adult, by administering safinamide to a human having ADHD, MDD, BED, or SWD. Safinamide can be administered in the morning, such as within one hour of waking. In some embodiments, safinamide is administered more than 9 hours before the expected bedtime.